https://www.selleckchem.com/products/OSI-906.html
Data were audited for the period before and after these introductions. RESULTS Of the 1163 consultations conducted in the 2-month period, the use of EpiNATO-2 PLUS captured an additional 169 patient contacts not collected by EpiNATO-2. The provision of a summary guide and teaching session decreased coding errors in the second audit period from 12.9% to 6.8% for EpiNATO-2 and from 19.4% to 6.6% for EpiNATO-2 PLUS, respectively. CONCLUSIONS The use of EpiNATO-2 PLUS collected a broader spectrum of medical activity in the Role 1 MTF, by ca